RxDoctor Payments Data

Matthew Dzurik

Foot & Ankle Surgery · Wilmington, NCNPI 1285895169

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.9%), consulting fees and other — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 60.5% of it on its own, with 18 other manufacturers making up the rest. Among foot & ankle surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,293in general payments, 2019–2025

Across 131 payments — averaging $1086.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$86K
  • In2bones USA, LLC$53K
  • Intelivation Technologies, LLC$2K
  • Amgen$337
  • Organogenesis Inc.$282
  • Smith+Nephew$162
  • plus $376 from 13 others

What the payments were for

  • Royalty or licence$81,00457%
  • Consulting fees$21,62515%
  • Speaking & faculty fees$11,0008%
  • Travel & lodging$6,2404%
  • Food & beverage$2,8612%
  • Other$19,56214%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Linvatec Corporation41$86,151
In2bones USA, LLC38$52,734
Intelivation Technologies, LLC3$2,250
Amgen(2 entities)20$337
Organogenesis Inc.7$282
Smith+Nephew7$162
Forma Medical1$70
Convatec Inc.2$55
Nevro Corp.2$35
Orthofix Medical, Inc.1$34
Ossio Inc1$28
AbbVie1$28
Abbott1$25
Stryker1$23
Zimmer Biomet1$19
Paratek Pharmaceuticals, Inc.1$16
Paragon 28, Inc.1$16
KCI USA, Inc.1$15
Zyla Life Sciences, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,293 in reported general payments places this provider in the 95th percentile of 196 foot & ankle surgery providers in North Carolina.

See all foot & ankle surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$158,252
Medicare patients
461
Services billed
1,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin129$1,265
Ondansetron OdtOndansetron93$1,166
Allopurinol86$897
Cephalexin97$712
Pregabalin20$492
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$296
Silver Sulfadiazine27$227
Doxycycline Hyclate31$223
Celecoxib19$217
Mupirocin34$195
Amitriptyline Hcl22$193
Doxycycline Monohydrate16$160
Meloxicam59$160
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$156
Methylprednisolone32$123

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →